Apollo Hospitals reports strong Q3FY24 performance with consolidated revenue growing by 14% YoY, EBITDA by 21%, and PAT by 60%. The company also launched a Paediatric ProHealth Programme and expanded its services in precision oncology and multi-specialty hospitals.